BioCentury | Sep 7, 2018
Financial News

SCM raises $35M series C for stem cells to treat inflammation

...investors last Friday to advance its pipeline of disease-specific mesenchymal stem cell therapies. Seoul-based investors DS Asset Management...
BioCentury | Jun 15, 2018
Financial News

ABL snags $65M in series C

...raised $65 million on June 8 in a series C round led by new investors DS Asset Management...
BioCentury | Jun 8, 2018
Financial News

ABL snags $65M in series C

...Seongnam, South Korea) raised $65 million in a series C round led by new investors DS Asset Management...
BioCentury | Dec 9, 2016
Financial News

T cell play Eutilex raises W21B in series A

...Ltd. (Seoul, South Korea) raised W21 billion ($18.9 million) in a series A round from DS Asset Management...
BioCentury | Dec 9, 2016
Financial News

Eutilex completes venture financing

...Eutilex raised W21 billion ($18.9 million) in a series A round from DS Asset Management, Kolon Investment, G.N...
Items per page:
1 - 5 of 5
BioCentury | Sep 7, 2018
Financial News

SCM raises $35M series C for stem cells to treat inflammation

...investors last Friday to advance its pipeline of disease-specific mesenchymal stem cell therapies. Seoul-based investors DS Asset Management...
BioCentury | Jun 15, 2018
Financial News

ABL snags $65M in series C

...raised $65 million on June 8 in a series C round led by new investors DS Asset Management...
BioCentury | Jun 8, 2018
Financial News

ABL snags $65M in series C

...Seongnam, South Korea) raised $65 million in a series C round led by new investors DS Asset Management...
BioCentury | Dec 9, 2016
Financial News

T cell play Eutilex raises W21B in series A

...Ltd. (Seoul, South Korea) raised W21 billion ($18.9 million) in a series A round from DS Asset Management...
BioCentury | Dec 9, 2016
Financial News

Eutilex completes venture financing

...Eutilex raised W21 billion ($18.9 million) in a series A round from DS Asset Management, Kolon Investment, G.N...
Items per page:
1 - 5 of 5